Study of the Oral Treatment MTR-601 in Cervical Dystonia
Status:
RECRUITING
Trial end date:
2026-08-03
Target enrollment:
Participant gender:
Summary
Study MTR-601-201 is an 8-week, randomized, placebo-controlled study to examine the safety, tolerability, and efficacy of MTR-601 in participants with cervical dystonia.